Outcomes of different steroid dosing regimens in critical Covid-19 pneumonia at a Kenyan hospital: A retrospective cohort study
The study found that high-dose steroids in the treatment of critically ill patients with COVID-19 pneumonia did not confer any mortality benefit and were associated with an increased risk of dysglycemia and superimposed infections.
Authors
- Nancy Kunyiha (ORCID: https://orcid.org/0000-0003-2257-1317)
- Jasmit Shah (ORCID: https://orcid.org/0000-0002-7957-5426)
- John Otieno Odhiambo (ORCID: https://orcid.org/0000-0003-2316-0464)
- Felix Riunga (ORCID: https://orcid.org/0000-0003-0409-8300)
- Charles Makasa
Institutions
- Aga Khan University Nairobi (KE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1371/journal.pone.0307265
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39